Ledger. Australian venture funding, tracked

Startup · $2.1m raised

Respirion Pharmaceuticals Pty Ltd

Developing inhaled RSP-1502 to treat resistant infection and inflammation in cystic fibrosis

Coverage

Stories naming Respirion Pharmaceuticals Pty Ltd. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

23 deals

Cheque-in: 17 ANZ startups – plus Brooki and The Memo – raised $59.61 million this week

A weekly roundup of funding deals by Australian and New Zealand startups, spanning baked goods, retail, health AI, beverages, edtech, solar, legal tech, and Western Australian medical research grants.

12 deals

Western Australia backs 12 medtech startup ideas with $5 million in Seed funding

WA's Innovation Seed Fund has awarded almost $5 million in grants to 12 researchers and startups for health projects, from liver cancer tests to endometriosis diagnosis, ranging from $90,000 to $500,000.

Also Startup Daily·Startup News (WA)

Funding announcement

Respirion offers hope for people living with cystic fibrosis

A Telethon Kids spin-out backed by Brandon Capital has begun trials in the US and Australia of RSP-1502, an inhaled antibiotic booster for cystic fibrosis lung infections, after strong early results in WA patients.

Funding announcement

Respirion offers hope for people living with cystic fibrosis

A Telethon Kids offshoot, Respirion Pharmaceuticals, is trialling its antibiotic-booster therapy RSP-1502 in the US and Australia, with backing from Brandon Capital and an American cystic fibrosis foundation.

8 deals

Funding Australia’s Future Economy: CUREator Deploys $7.21 Million to Propel local Life Sciences Potential

CUREator, Brandon BioCatalyst's government-backed grant program, has awarded $7.21 million across eight Australian biotech firms in its newest round, split between clinical-stage and preclinical recipients.

Also Brandon BioCatalyst portfolio·Startup Daily·ausceleratesa.org

Something wrong? Tell us